Health & Biotech
Weed Week: Germany’s plans to legalise cannabis rekindle North American investment spark in Europe
Health & Biotech
ASX Biotech Stocks: Neurotech reports positive paediatric autism results and Arovella to close Perth R&D facility
Health & Biotech
Stock Insiders: Skin Elements aims to commercialise three all-natural product ranges
Health & Biotech
Australia’s natural COVID killing disinfectant makes waves in Hong Kong
Health & Biotech
Prescient shows that PTX-100 is safe and effective on difficult to treat T-cell lymphomas
Health & Biotech
ASX Biotech Stocks: Estia picks up 4 new aged care homes; MGC flags positive result for long COVID symptoms
Health & Biotech
ASX Health Stocks: Memphasys plans in vivo studies in Japan, Canada; ECS sells Tassie assets
Health & Biotech
Dr Boreham’s Crucible: Go Woke, go broke? Early signs say no concerns with this pyschedelic IPO
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rattling the tin, Telix shares soar ~26% on positive quarterly results
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
Health & Biotech
Vida Ventures MD says it’s a rosy outlook for biotech investment in Australia in the long run
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.